• Home
  • Search Results

Search Results

Older Adult (65+)
2144 studies match your search
Open

Immunotherapy study for patients with stage II-III breast cancer

Do you have Stage II or III Breast cancer? If you have enough tissue from your breast cancer diagnosis to send for Mammaprint genomic testing, you may be able to take part in this research study. In this study, we want to learn more about adding an immunotherapy drug, durvalumab, to your chemotherapy treatment. The Mammaprint testing is conducted at no cost to you and the cost of durvalumab is covered.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Breast)
Open

Adults with Blood Cancer

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AZD9829 to patients with Leukemia.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Randomized Phase III Trial of mFOLFIRINOX vs. FOLFOX With Nivolumab

Can we extend your life after the diagnosis of your cancer in the stomach, esophagus, or gastroesophageal junction by adding a third chemotherapy drug to the usual combination of two chemotherapy drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for treatment of your cancer in the stomach, esophagus, or gastroesophageal junction. The usual approach is defined as care most people get for cancer in the stomach, esophagus, or gastroesophageal junction.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Stomach and Esophageal)
Not currently enrolling

Individualizing Treatment for Asthma in Primary Care

This is a research study to compare the safety and effectiveness of two different ways to treat asthma. The first way is adding inhaled corticosteroids to your rescue medication (the medicine that opens your airways quickly). The second way it using an antibiotic over time. These treatments will be used alone or together and compared to usual care plus a system to track asthma symptoms at home. We hope to find out who will do best with each type of treatment, which is not known at this time.

Age & Gender
  • 13 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Lungs and Breathing
Open

Advanced Melanoma Tumor Study

Do you have an advanced melanoma tumor and have received prior systemic therapy? Has your cancer progressed on the other treatments? If so, the you may be able to take part in a study to help us learn the safety and dosage of the drug AB248 on solid tumors.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)
Not currently enrolling

HPV vaccination perception among rural NC parents /Opiniones sobre la vacuna del VPH entre padres y madres de zonas rurales de Carolina del Norte

Interview rural parents of diverse racial and ethnic backgrounds to explore and understand parents' preferences on how their primary care providers discuss HPV vaccination with them, with the goal of increasing vaccination rates in rural NC and among underrepresented minority populations (Hablamos español). / Entrevistar a padres y madres de diferentes grupos étnicos y raciales para comprender como prefieren hablar sobre la vacuna del VPH con sus médicos de atención primaria. El objetivo es mejorar las tasas de vacunación en las zonas rurales de Carolina del Norte y entre las minorías.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Minority Health
  • Opinions and Perceptions
  • Parents of Children
Visit Location
100% Remote (online, phone, text)
Open

Randomized Phase 2 Study of Cabozantinib, Ipilimumab, and Nivolumab in Patients With Soft Tissue Sarcoma

Do you have advanced soft tumor sarcoma? Is your tumor surgically unresectable? If so, then you may be able to take part in a study to help us learn if a combination of 3 study drugs will affect the progression of Soft Tissue Sarcoma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Sarcoma (bone and soft tissue))
Not currently enrolling

An Analysis of Cultural Competence in CPR Instruction

In a descriptive study, we intend to explore the comparative efficacy of culturally tailored CPR training, with five components: language variations, cultural adaptations, sex/age-specific instruction, socioeconomic adaptations, and consideration of cultural learning styles. By examining these components, we seek to identify the most effective and culturally sensitive approaches to CPR education. The primary goal is to develop a culturally tailored CPR training curriculum that raises confidence levels of individuals in performing bystander CPR, thus increasing bystander CPR rates and the likelihood of positive cardiac arrest outcomes.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Heart and Circulation
  • Healthy Volunteer or General Population
Not currently enrolling

North Carolina Archival Flood Risk Assessment

The purpose of this study is to investigate North Carolinian archival repositories' disaster preparedness for climate change induced flood risks.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Environment
  • Opinions and Perceptions
Visit Location
100% Remote (online, phone, text)
Open

South Asian Menstrual Equity research study

Do you identify as South Asian and do you menstruate? Do you identify as South Asian and do you use or have you consider using contraception or birth control? Have you experienced bias when discussing menstruation or contraception? If so, you may be interested in this study to improve reproductive justice for South Asians in the United States.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Behavior
  • Women's Health
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research